Service Communautaire d'Information sur la Recherche et le Développement - CORDIS

Les informations sur les projets et maintenant aussi les résumés de rapports Horizon 2020 sont disponibles sur CORDIS. Tous les projets H2020 peuvent être téléchargés depuis le Portail des données ouvertes de l'UE .

My refinements


Download results of this page


Affiner par:

Type de contenu

Projet (102)
Résumé de rapport (6)

Advanced search

Rechercher des projets et résultats

Results 1 - 10 of 108
Results/page:
12 3 4 5 6 7 8 9 10 > >| 
Improving Diagnosis by Fast Field-Cycling MRI
ID: 668119
Date de début: 2016-01-01, Date de fin: 2019-12-31
Many diseases are inadequately diagnosed, or not diagnosed early enough by current imaging methods. Examples of unmet clinical needs arise in thromboembolic disease, osteoarthritis, cancer, sarcopenia, and many more areas. Our solution, Fast Field-Cycling (FFC) MRI, can...
Programme: H2020-EU.3.1.3.
Record Number: 199749
Last updated on: 2017-06-23
VISION-DMD - Phase 2 Clinical Trials of VBP15: An Innovative Steroid-like Intervention on Duchenne Muscular Dystrophy
ID: 667078
Date de début: 2016-01-01, Date de fin: 2019-12-31
VISION-DMD aims to advance clinical development of the orphan drug VBP15 as a new therapy to revolutionise care for all patients with Duchenne muscular dystrophy (DMD) by 2020, in line with IRDiRC goals. DMD is an incurable, rare muscle wasting disease; boys progressively...
Programme: H2020-EU.3.1.3.
Record Number: 199721
Last updated on: 2017-05-10
Development of an innovative gene therapy platform to cure rare hereditary muscle disorders
ID: 667751
Date de début: 2016-01-01, Date de fin: 2019-12-31
The objective of MYOCURE is to develop an innovative gene therapy platform to cure rare hereditary muscle disorders, specifically focusing on myotubular myopathy (MTM) and glycogen storage disorder (GSD) type II. These are attractive diseases for gene therapy since they...
Programme: H2020-EU.3.1.3.
Record Number: 199738
Last updated on: 2016-11-29
Validation of a point-of-care H-FABP test for a rapid exclusion of Acute Myocardial Infarction in patients with cardiac complaints.
ID: 666666
Date de début: 2015-04-01, Date de fin: 2017-10-31
There is a pressing need for improvement of the diagnosis of acute myocardial infarction (AMI) for healthcare professionals (HCP). 1–1,5% of the population consult a physician each year with chest pain complaints. While the majority (60–80%) of these patients are sent to a...
Programme: H2020-EU.3.1.3.
Record Number: 197911
Last updated on: 2016-12-23
bLadder cAncer URine cEll aNalysis
ID: 673664
Date de début: 2015-06-01, Date de fin: 2018-07-31
Bladder cancer is the 4th most common cancer in men and the 7th in women, with 330,000- 380,000 new cases annually worldwide or more than 150,000 in Europe and is one of the most expensive cancers to manage. Bladder cancer incidence is strongly related to age, with the...
Programme: H2020-EU.3.1.3.
Record Number: 197552
Last updated on: 2016-10-10
Restoring tissue regeneration in patients with visceral Graft versus Host Disease.
ID: 643580
Date de début: 2015-01-01, Date de fin: 2021-12-31
Stem cell regenerative therapies hold great promise for patients suffering from a variety of disorders that are associated with tissue or organ injury. Regeneration relies on tissue or organ-specific stem and progenitor cells, but can also aim at promoting the endogenous...
Programme: H2020-EU.3.1.3.
Record Number: 194081
Last updated on: 2017-07-24
ERA-NET for establishing synergies between the Joint Programming on Neurodegenerative Diseases Research and Horizon 2020
ID: 643417
Date de début: 2015-01-01, Date de fin: 2019-12-31
Over 12 million people in Europe suffer from neurodegenerative diseases (ND), yet treatments that prevent or stop the progression of neurodegeneration are still lacking. Tackling this grand challenge requires enhanced coordination of national efforts to accelerate discovery...
Programme: H2020-EU.3.1.3.
Record Number: 194063
Last updated on: 2017-08-22
Regenerative treatment of complete Traumatic Spinal Cord injury with a surgical implantation of a biodegradable device with FGF1 and nerve grafts
ID: 643853
Date de début: 2015-01-01, Date de fin: 2018-12-31
Today there is no regenerative therapy available for treatment of complete spinal cord injuries (SCI). BioArctic Neuroscience develops a novel treatment of complete SCI. The method is based on the regeneration of functional nerves in the injured spinal cord. Nerve grafts are...
Programme: H2020-EU.3.1.3.
Record Number: 194111
Last updated on: 2017-07-17
Repair of tissue and organ damage in refractory chronic graft versus host disease after hematopoietic stem cell transplantation by the infusion of purified allogeneic donor regulatory T lymphocytes
ID: 643776
Date de début: 2015-01-01, Date de fin: 2019-12-31
Our proposal encompasses parallel clinical trials addressing the feasibility and the effectiveness of donor-derived regulatory T cells (Treg) as a therapeutic agent in the treatment and prevention of tissue and organ damage resulting from graft versus host disease (GVHD) after...
Programme: H2020-EU.3.1.3.
Record Number: 194101
Last updated on: 2017-07-14
Genomic diagnostics beyond the sequence
ID: 634890
Date de début: 2015-05-01, Date de fin: 2019-04-30
Cytogenetic diagnostic approaches provide information on the single-chromosome level but suffer from low resolution and throughput. In contrast, next generation sequencing (NGS) based diagnostics provides single base resolution and high throughput but suffer from short reads...
Programme: H2020-EU.3.1.3.
Record Number: 193312
Last updated on: 2017-08-17
12 3 4 5 6 7 8 9 10 > >| 
List retrieved on: 2018-06-24